Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 3 search results for "Inflectra" in Resources. To see all results and access other features, sign up for free.

... If NSAIDs do not adequately control inflammation, rheumatologists may prescribe biologic medications, such as adalimumab (Humira), infliximab-dyyb (Inflectra), or golimumab (Simponi). ...
What Is Spondylitis?
... If NSAIDs do not adequately control inflammation, rheumatologists may prescribe biologic medications, such as adalimumab (Humira), infliximab-dyyb (Inflectra), or golimumab (Simponi). ...
... Disease-modifying antirheumatic drugs, such as methotrexate, adalimumab (Humira), infliximab (Inflectra), and golimumab (Simponi), can help delay fusing of the vertebral bodies of the spine. These treatments may prevent or delay the progression of axial spondyloarthritis from evolving to radiographic axial spondyloarthritis. ...
Spondylitis vs. Spondylosis: Are They One and the Same?
... Disease-modifying antirheumatic drugs, such as methotrexate, adalimumab (Humira), infliximab (Inflectra), and golimumab (Simponi), can help delay fusing of the vertebral bodies of the spine. These treatments may prevent or delay the progression of axial spondyloarthritis from evolving to radiographic axial spondyloarthritis. ...
... The mainstay treatments for spondyloarthritis are disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and biologic tumor necrosis factor (TNF) inhibitors adalimumab (Humira), infliximab-dyyb (Inflectra), and golimumab (Simponi).Starting treatment early can delay or even prevent irreversible spine curvature, limited mobility, and disability ...
Is Axial Spondyloarthritis Underdiagnosed in Women?
... The mainstay treatments for spondyloarthritis are disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and biologic tumor necrosis factor (TNF) inhibitors adalimumab (Humira), infliximab-dyyb (Inflectra), and golimumab (Simponi).Starting treatment early can delay or even prevent irreversible spine curvature, limited mobility, and disability ...